Actively Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
Led by Beijing Tongren Hospital · Updated on 2024-08-09
135
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 270 patients at Beijing Tongren Hospital. All treatments were self-administered by the patients at home after training at the hospital. Patients completed questionnaires at baseline, 1 month, 3 months, and 6 months. OSDI score, TBUT, OPAS, NPSI-eye, and Schirmer I expressibility and secretion score to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.
CONDITIONS
Official Title
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years
- Clinical diagnosis of dry eye disease with meibomian gland dysfunction
You will not qualify if you...
- History of depression, tumors, thyroid disease, diabetes, or cardiac diseases
- History of ear, nose, or throat surgery
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Beijing TongRen Hospital, Capital Medical University Beijing, China
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
D
Dong Wu, Doctor
CONTACT
H
Haihong Lian, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here